Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index; none of the 76 sources its claims cite is checked for support yet.

ALARM NMR for HTS Triage and Chemical Probe Validation

Open access

Abstract

Nonspecific target engagement by test compounds and purported chemical probes is a significant source of assay interference and promiscuous bioactivity in high‐throughput screening (HTS) and chemical biology. Most counter‐screens for thiol‐reactive compounds utilize mass spectrometry or fluorescence detection, as well as nonproteinaceous reporters like glutathione that may not always approximate the reactivity of protein side chains. By contrast, a L a a ssay to detect r eactive m olecules by n uclear m agnetic r esonance (ALARM NMR) is an industry‐developed protein‐based [1 H‐13 C]‐heteronuclear multiple quantum coherence NMR counter‐screen to identify nonspecific protein interactions by test compounds by reporting their tendencies to modulate the human La antigen conformation. This article is a user's guide to the production of the 13 C‐labeled La antigen reporter protein and reaction of test compounds with this reporter protein, as well as the collection and analysis of characteristic NMR spectra. Combined with other assay interference counter‐screens, this assay will enhance chemical biology by helping researchers better prioritize chemical matter, which will increase the number of tractable HTS screening actives and aid in the development of better chemical probes. © 2018 by John Wiley & Sons, Inc.

Overview

CoChat Summary

TL;DR

ALARM NMR is a protein-based [1H-13C]-HMQC counter-screen using a 13C-methyl-labeled human La antigen reporter to flag thiol-reactive or nonspecific protein-perturbing compounds in HTS triage and chemical probe validation. This Current Protocol provides step-by-step methods for producing the labeled La reporter protein, running the ±DTT assay, and interpreting the resulting NMR spectra.

Key findings

  • ALARM NMR detects thiol-reactive compounds through DTT-dependent decreases and/or shifts at 13C-labeled leucine peaks L249, L294, and L296; nonspecific/aggregating compounds perturb the La antigen conformation independent of DTT, while nonreactive compounds such as fluconazole show minimal changes.
  • In one drug discovery setting, 10/34 (29%) compounds negative by conventional GSH reactivity screens were flagged as thiol-reactive by ALARM NMR; some HTS campaigns had ALARM NMR-positive hit rates approaching 50%.
  • The protocol reports 13C-methyl incorporation can exceed 90%, expected protein yield >20 mg per L bacterial culture, default assay conditions of 50 μM protein and 400 μM test compound (8:1 compound:protein) ±20 mM DTT, and that approximately 50% of total cysteines must be covalently modified to trigger an ALARM NMR-positive readout.
  • Chemical probes (+)-JQ1, A395, T-26c, and GSK-6853, as well as targeted covalent modulators ibrutinib and FM-381, are ALARM NMR-negative; ampicillin is negative, while more reactive cephalosporins are ALARM NMR-positive.

Methods

  • Basic Protocol 1 expresses human La antigen residues 100–324 with N- and C-terminal 6xHis tags from pET28b+ in Rosetta(DE3)pLysS cells in M9 media; 13C-methyl labels are incorporated using [3-13C]-α-ketobutyrate (200 mg/L) and [3,3-13C]-α-ketoisovalerate (300 mg/L), followed by 1 mM IPTG induction, Ni-NTA purification, dialysis, and storage.
  • Basic Protocol 2 reduces the La reporter with 20 mM DTT and dialyzes under N2; reactions contain 50 μM protein, 400 μM test compound, 25 mM sodium phosphate pH 7.0, 10% D2O, with or without 20 mM DTT, incubated at 37 °C for 1 h then room temperature for 16 h before [1H-13C]-HMQC/HSQC acquisition at 310 K.
  • Data analysis is qualitative: L249/L294/L296 peak intensities and shifts are compared to DMSO controls; >~30% intensity reduction is scored positive, 10–30% equivocal, and <10% negative; DTT-dependent positives are thiol-reactive, while DTT-independent positives indicate nonspecific perturbation.

Limitations

  • Stated in the paper: ALARM NMR requires NMR instrumentation, 13C-labeled amino acid precursors are costly, and high protein/compound concentrations can be problematic for poorly soluble compounds or samples with trace impurities; a negative ALARM NMR result does not conclusively exclude thiol reactivity against other proteins, and the assay does not identify reactivity at lysine residues.
  • Stated in the paper: the readout is qualitative, aggregators can perturb the La antigen independent of DTT, and rare redox-active compounds may perturb only in the presence of DTT; ALARM NMR-positive compounds are usually deprioritized, but tractable compounds may still react with the La reporter.
  • Evident from the text: this is a methods protocol rather than a primary validation study, and throughput is constrained by protein production (approximately one week) and NMR time (~25 min per sample; ~45 min per compound), although several hundred compounds per week is claimed with appropriate instrumentation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/cpch.35

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 5 Not valid · 52 Not checked · 47 Own results and interpretations

44 more claims

Create a free account to see all 104 claims and to verify the 56 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 41

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. Dahlin J. L., 2015, Assay guidance manual

Cited by

See all 28

Metadata

Authors
Dahlin, J. L., Cuellar, M., Singh, G., Nelson, K. M., Strasser, J. M., Rappe, T., Xia, Y., Veglia, G., & Walters, M. A.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Minnesota (US)
Venue
Current Protocols in Chemical Biology
Publisher
Wiley
Published
2018-03
Volume
10
Issue
1
Pages
91-117
ISSN
2160-4762 (ISSN-L)
OpenAlex
W2797960269
Cited by
25
References
58
Citations by year
2026: 3 · 2023: 6 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 2 · 2018: 1
FWCI
1.34
Type
journal article
Language
en
Open access
Locations
  • Current Protocols in Chemical Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Minnesota Foundation
  • National Institutes of Health
  • Directorate for Biological Sciences
  • National Institute of General Medical Sciences (R01GM100310)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
La antigen, nonspecific protein binding, high-throughput screening, HMQC, assay interference, protein conformation
MeSH terms
Humans, Proteins, Reproducibility of Results, Molecular Probes, Leukocyte Common Antigens, Nuclear Magnetic Resonance, Biomolecular, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ALARM NMR for HTS Triage and Chemical Probe Validation. https://app.cochat.ai/papers/10.1002/cpch.35
The paper
Dahlin, J. L., Cuellar, M., Singh, G., Nelson, K. M., Strasser, J. M., Rappe, T., Xia, Y., Veglia, G., & Walters, M. A. (2018). ALARM NMR for HTS Triage and Chemical Probe Validation. Current Protocols in Chemical Biology. https://doi.org/10.1002/cpch.35

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.